Non-Ventilator Management of Respiratory
Failure: The Ventimask*
WILLIAM B. HUNT, JR., M.D.

Associate Professor of Internal Medicine, Allergy-Pulmonary Division,
University of Virginia School of Medicine, Charlottesville, Virginia

The Problem-Acute Respiratory Failure in
Chronic Obstructive Pulmonary Disease. In a
recent review the authors comment on acute respiratory failure complicating chronic obstructive
pulmonary disease. They state that because of
the tolerance to chronic hypoxemia, the recurrent nature of the Jung failure, and the increased
number of complications during mechanicai ventilation, "artificial ventilation is not indicated until all other attempts have failed to reverse hypoxemia without causing hypocapnia" ( 2).
This paper will detail the conservative management of acute respiratory failure in patients
with chronic respiratory failure due to chronic
bronchitis and emphysema. It is important to recognize that this is a very specific group of patients.
They have had chronic hypoxia and hypercarbia
for months or years preceding their current episode
of acute respiratory failure. There occurs a further
drop in arterial P 0 , (Pa 0 ,) and usually a further
rise in arterial Pco, (Pac 0 ,). The baseline arterial
Pa 0 ,, Paco,, and pH in _such -,palients _.ar.e_ lJSUaily
as follows:
Pao,
Paco,
pH

50 mm Hg
45 mm Hg
7.4

Because of infection, sedation, heart failure, associated asthma, and so forth, they usually pre-

* Presented by Dr. Hunt at the Symposium on Respiratory Failure, May 26, 1972, at Richmond, Virginia.
1 The ventimask can be obtained from The Bethlehem
Corporation, 225 W. Second Street, Bethlehem, Pennsylvania.
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sent to their physician with increasing dyspnea,
cyanosis, disorientation, and commonly the following arterial gases and pH:
Pao,
40 mm Hg
Paco, = 55 mm Hg
pH
= 7.35
Remember that the statements in this paper do
not apply to asthma, only to chronic bronchitis and
emphysema.
The Therapeutic Goal. The physician must
increase the Pa 0 , "significantly" with "little increase" in Paco, and ''little decrease" in pH. While
this stopgap measure keeps the patient alive, therapeutic efforts are directed toward complicating
diseases responsible for the acute respiratory failure.
An attempt will be made to define the vague term
"significant decrease" in Pa 0 ,, and " little decrease"
in pH.
The Tool-'the Ventimask. 1 Since this group
of patients has had an elevated Paco, for varying
periods of time, ventilation is keyed to the low
-arterial -oxygen, rather than to the C0 2 partial
pressure. The usual methods of oxygen delivery, the
nasal catheter and face mask, deliver 30% to 40%
oxygen, enough to lethally depress ventilation.
The ventimask represents a method by which
the physician can deliver low flow oxygen inexpensively and with safety. Because of the Venturi effect,
the 100% oxygen that flows into the mask will entrain
room air (21 % 0 2) through the side ports of the
mask (fig. I). Four liters of oxygen flow per minute
is necessary to achieve the 24% 0 2 concentration in
the mask. However, further increases in flow will
merely draw more 21% oxygen into the mask, and
by clever engineering the oxygen concentration in
the mask is therefore kept constant at 24%. The 28%
141
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Fig. 1-The 24 % ventimask.

ventimask is similar in all respects except that the
final F1 0 , is 28%.
Guidelines for Arterial Gases.
Arterial Oxygen. When the Pa 0 , falls below
50 mm Hg, pulmonary capillary vasoconstriction
occurs, and pulmonary hypertension occurs or is
accentuated. Pa 0 , below 40 will decrease sodium and
free water excretion and may depress ventilation .
In this range (40 or below) digitalis intoxication is
markedly accentuated and ventricular arrhythmias
occur.
In practice then, the immediate goal of therapy
should be to increase the Pa 0 , from 30- 40 mm Hg
to the 45- 55 mm Hg range. This frequently can be
done with the 24% ventimask, remembering that an
increase in inspired oxygen concentration (F1 0 ,)
from 21% (room air) to 24% is really 3% of an
atmosphere (760 mm Hg) or approximately 21 mm Hg.
Since in patients with chronic bronchitis and emphysema ventilation is usually reduced to many
alveoli, the alveolar 0 2 (Pa 0 ,) of 128 mm Hg (as in
fig. l) is usually reduced so that the increase m
Pa 0 , is more like lO mm Hg than 21 mm Hg.
But it is very important to note that this lO
mm Hg change in Pa 0 , is on the steep portion of the
oxyhemoglobin dissociation curve (fig. 2) and will

actually nearly double the oxygen delivered at the
tissue level.
Guidelines for Paco, and pH. Except for its
narcotic properties, Pa c o, elevation per se is probably
not important but may be used as a guide to oxygen
delivery. If the 24% ventimask therapy results in a
lO mm Hg increase in Pa 0 , and at the same time
elevates the Pa co, greater than 5 mm Hg, further
increase in oxygen concentration should not be
attempted. If the Paco, remains the same or is
reduced then one can safely go on to a 28% ventimask
and another 4% (28 mm Hg) increase in F1 0 , . A
Pa c o, greater than 65 mm Hg may decrease salt and
free water excretion, but this can usually be overcome
with the use of diuretics (Lasix ® not ethacrynic acid).
The pH, however, is critical. Many vital enzyme systems do not work as the pH falls below
7 .2, and hydrogen ion elevation will also cause
pulmonary capillary vasoconstriction.
If the pH can be kept between 7 .3 and 7 .4
and does not remain consistently below 7.2, and
if the patient remains conscious and able to cough,
then conservative therapy should be continued.
General Measures. Dr. E. J. M. Campbell
has said, "controlled oxygen therapy plus ineffectual nursing is better than uncontrolled oxygen
plus ineffectual nursing only because the patient
gets into less trouble" ( 1). The most important factor immediately is nursing care.
The patient should be:
1. In a chair, not flat in bed.
2. In a lighted room or corridor for the first
24 hours for observation and stimulation.
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Fig. 2-Increase in Pa.., on 24 % ventimask. "Available"
means available at the tissue level (modified after Campbell) .
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3. Receiving chest physiotherapy each hour
from the floor nurse or relatives or at least
encouraged to cough and breathe deeply
every 15 minutes.
4. Encouraged to use a pressure regulated
IPPB machine (Bird or Bennett) five
minutes out of every 30 or 60 minutes
(without Isuprel®) . This is for "stir-up,"
cough, and stimulation not specifically for
ventilation.
Specific Therapy. In general, there is no
"specific therapy" for chronic bronchitis . and ei_nphysema, so that complications or associated diseases must be diligently searched for and vigorously treated if present. One must not blindly
and mindlessly treat each patient with chronic
bronchitis and emphysema with digitalis, antibiotics, diuretics, steroids, and broncholytic agents.
Mucolytics. There are none that are effective.
Acetyl cysteine (Mycomyst® ) may actually aggravate any bronchospasm that may be present.
Robitussin® should be reserved for your grandmother who has a " tickle in her throat."
Look for and treat :
1. Left ventricular failure . This is most easily diagnosed by an upright chest x-ray showing
pulmonary venous engorgement in the upper lobes
or Kerley B lines (fig. 3). Obvious pulmonary
edema, whether unilateral or mild, should be
suspected and searched for . Treat vigorously with
Lasix® and replace K losses with KC! not K-Triplex. Digoxin should be used judiciously. The right
ventricle will respond to digitalis, but toxicity may
occur at half the usual digoxin level when the
Pa 0 , is below 50 mm Hg.
2. Asthma. Eosinophils in the blood or on
H ansel stain 2 of the sputum suggest a diagnosis
of asthma. Suspect this diagnosis if the patient
does not smoke, is under 50, or has a childhood
history of asthma. If asthma is not present, Isuprel® can accentuate hypoxemia and in the already
hypoxemic individual, aminophylline, adrenalin,
and ephedrine may cause dangerous arrhythmias.
In the patient with chronic bronchitis and emphysema in respiratory failure without prior evidence
of a good response, certainly Isuprel® and prob-

2 Hansel stain may be obtained from Lide Laboratories,
6828 Oakland Avenue, St. Louis, Mo. 63139-$7.50 for 8
ounces.

Fig. 3-The arrows indicate the position of Kerley B lines.
The pulmonary veins are shown in black.

ably the other bronchodilator drugs are contraindicated.
Steroid therapy (prednisone 40-60 mg daily)
in patients with associated asthma may be life
saving. An intermediate PPD should be done on
every patient on admission prior to the institution of steroids and, if positive, isoniazid therapy should be considered, depending on the duration of the steroid therapy and the appearance
of the chest x-ray.
3. Infection. The sputum should be observed,
stained (both Gram and Hansel), and cultured
if grossly purulent. Infrequently, grossly purulent
sputum can be due to the presence of eosinophils
alone. Usually acute purulent bronchitis is the
the cause. The most common pathogens found are
the pneumococcus or hemophilus influenza. Since
probably 10% of all strains of streptococcus pneumonia are resistant to tetracycline, ampicillin 2 g
daily is the treatment of choice (unless penicillin sensitivity is present).
4 . Pneumonia: A chest x-ray must be obtained. The use of a stethoscope alone in the examination of the emphysematous chest is grossly
inadequate. The presence of pneumonia in the patient with acute respiratory failure constitutes a
medical emergency. Unless the overwhelmingly
predominant organism can be identified by gram
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stain and quellung 3 as a pneumococcus, cephalothin and gentamycin should be used for 48
hours until the results of the sputum culture are
available. You do not have time to be wrong,
then switch.
5. Cor pulmonale. Rapid, effective, specific
therapy for the right heart failure of cor pulmonale in these patients is not available. The patient has right heart failure primarily because he
is hypoxemic, and you cannot rapidly relieve his
hypoxemia or he will underventilate, become unconscious, needing intubation and mechanical
ventilation, and this is what you are trying to
avoid. As mentioned above, digitalis will improve
the function of the right ventricle but must be
used cautiously. If the patient has not been given
digitalis in the past, digoxin 0.25 mg daily without a loading dose is the preferable technique.
A reduction in pulmonary blood volume, ascites,
and pleural effusion all may improve pulmonary
function so that aggressive diuretic therapy may
be indicated. Ethacrynic acid may produce underventilation and should be avoided. Currently
Lasix® is the drug of choice. Thoracentesis may
produce a lethal pneumothorax and should be
avoided unless a massive efjusion is present. There
is no evidence that phlebotomy is an effective
method of therapy under these circumstances.
Sedation. If over sedation with morphine or
pentazocine is suspected, naloxone (narcan) is specific therapy and can be given without risk of further
sedation. If other drugs (Valium®, meprobamate, and
so forth) are known to have been primarily responsible for the respiratory depression, then it becomes even more imperative that vigorous attempts be made to keep the patient awake for the
first 24 hours of therapy. It should be noted here
that it is self-defeating to keep patients awake
continuously for more than 24 hours. At the end
of that time, alternating naps with arousal every
30 minutes to one hour becomes necessary.
3 Quellung reagent may be obtained as "Omniserum"
from Statens Seruminstitute, Amager Boulevard 80, DK2300, Copenhagen S, Denmark.
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When to Intubate. Reduced consciousness
and an inability to cough are the major indications for intubation and ventilation. Inability to
achieve an arterial Pa 0 , greater than 30 mm Hg
or maintain a pH greater than 7 .2 after 24 hours
of therapy are relative indications for intubation.
But, one should never act precipitously on a single number obtained from the laboratory that
does not fit the clinical course that has been observed.
Emergency tracheostomy should never be
done without prior intubation. Ideally a period of
mechanical ventilation with achievement of good
oxygenation and reversal of the respiratory acidosis should be accomplished prior to tracheostomy.
Summary. Low flow oxygen therapy should
be given a trial in all conscious patients presenting
with acute respiratory failure due to chronic bronchitis and emphysema. The tolerance of these
patients to hypoxemia and hypercarbia make this
means of therapy possible. The ventimask is an
effective, inexpensive method of administering low
flow oxygen, with the added attraction that the
oxygen concentration cannot be inadvertently increased. Nursing care and aggressive therapy of
complicating or associated medical problems are
the key to successful management.
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